45 related articles for article (PubMed ID: 25809367)
1. An on-demand bioresorbable neurostimulator.
Lee DM; Kang M; Hyun I; Park BJ; Kim HJ; Nam SH; Yoon HJ; Ryu H; Park HM; Choi BO; Kim SW
Nat Commun; 2023 Nov; 14(1):7315. PubMed ID: 37951985
[TBL] [Abstract][Full Text] [Related]
2. Drug-coated balloon and stent therapies for endovascular treatment of atherosclerotic superficial femoral artery disease.
Banerjee S; Sarode K; Mohammad A; Brilakis ES
Curr Cardiol Rep; 2015 May; 17(5):36. PubMed ID: 25894799
[TBL] [Abstract][Full Text] [Related]
3. Comparison between diabetic and non-diabetic patients after successful percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era.
Ruiz-Garcia J; Teles R; Rumoroso JR; Cyrne Carvalho H; Goicolea FJ; Moreu J; Mauri J; Mainar V; García E; Moreno R;
Rev Port Cardiol; 2015 Apr; 34(4):263-70. PubMed ID: 25840644
[TBL] [Abstract][Full Text] [Related]
4. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
[TBL] [Abstract][Full Text] [Related]
5. A call for an evidence-based approach to the Heart Team for patients with severe aortic stenosis.
Coylewright M; Mack MJ; Holmes DR; O'Gara PT
J Am Coll Cardiol; 2015 Apr; 65(14):1472-80. PubMed ID: 25857913
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database.
Lai CL; Wu CF; Kuo RN; Yang YY; Chen MF; Chan KA; Lai MS
PLoS One; 2015; 10(4):e0122860. PubMed ID: 25848942
[TBL] [Abstract][Full Text] [Related]
7. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
8. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
[No Abstract] [Full Text] [Related]
9. Innovations in the Endovascular Management of Critical Limb Ischemia: Retrograde Tibiopedal Access and Advanced Percutaneous Techniques.
Mustapha JA; Diaz-Sandoval LJ; Saab F
Curr Cardiol Rep; 2017 Aug; 19(8):68. PubMed ID: 28646446
[TBL] [Abstract][Full Text] [Related]
10. [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].
Herten M; Stahlhoff S; Imm B; Schönefeld E; Schwindt A; Torsello GB
Radiologe; 2016 Mar; 56(3):240-53. PubMed ID: 26885653
[TBL] [Abstract][Full Text] [Related]
11. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.
Varcoe RL; Schouten O; Thomas SD; Lennox AF
JACC Cardiovasc Interv; 2016 Aug; 9(16):1721-8. PubMed ID: 27539693
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Results of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Infrapopliteal Arteries.
Varcoe RL; Thomas SD; Lennox AF
J Endovasc Ther; 2018 Dec; 25(6):694-701. PubMed ID: 30205736
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease.
Dia A; Venturini JM; Kalathiya RJ; Besser S; Estrada JR; Friant J; Paul J; Blair JE; Nathan S; Shah AP
Vascular; 2021 Jun; 29(3):355-362. PubMed ID: 32921290
[TBL] [Abstract][Full Text] [Related]
14. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
[TBL] [Abstract][Full Text] [Related]
15. Endovascular intervention for tibial artery occlusive disease in patients with critical limb ischemia.
Huang ZS; Schneider DB
Semin Vasc Surg; 2014 Mar; 27(1):38-58. PubMed ID: 25812758
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with the absorb bioresorbable vascular scaffold below the knee: six-month clinical and imaging outcomes.
Varcoe RL; Schouten O; Thomas SD; Lennox AF
J Endovasc Ther; 2015 Apr; 22(2):226-32. PubMed ID: 25809367
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
